Originally Published IVD Technology May 2005
Tenth Anniversary
Top 10 European IVD Markets
 |
The following list presents the top European IVD markets based on 2003 revenue figures. In 2003, IVD sales in the European Union (EU) totaled $8.5 billion, accounting for 31% of the world IVD market. Increased growth in the smaller, less mature IVD markets (e.g., Finland, Greece, Ireland, Luxembourg, Portugal) helped maintain overall growth at 6% per year. The EU market share of these countries has grown from 5% in 1996 to 10% in 2003. The continued expansion of diagnostics in not only these countries but also in the new EU members provides market growth, while the more developed countries pull back resources from healthcare spending. It is estimated that the market for IVDs in the EU will reach $11.7 billion by 2008. The following figures were provided courtesy of Kalorama Information (New York City) and were taken from Kalorama’s report, “The Worldwide Market for In Vitro Diagnostic Tests.” More information about this report can be accessed via the Kalorama Web site at www.kaloramainformation.com.
1. Germany
Revenues: $2.225 billion
EU market share: 26%
2. Italy
Revenues: $1.489 billion
EU market share: 17%
3. France
Revenues: $1.407 billion
EU market share: 16%
4. Spain
Revenues: $877 million
EU market share: 10%
5. United Kingdom
Revenues: $703 million
EU market share: 8%
6. The Netherlands
Revenues: $265 million
EU market share: 3%
7. Belgium
Revenues: $258 million
EU market share: 3%
8. Switzerland
Revenues: $242 million
EU market share: 3%
9. Austria
Revenues: $228 million
EU market share: 3%
10. Others
Revenues: $893 million
EU market share: 10%
Copyright ©2005 IVD Technology
